Cargando…

Retinal Thickness as a biomarker of cognitive impairment in bipolar disorder

INTRODUCTION: Ocular Coherence Tomography (OCT) to measure retinal thickness is the current method to observe neurological impairment in neurodegenerative diseases [1] and in mental disorders [2] due to the composition of the retina itself as an anatomic extension of the brain.There can be found som...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Corres, E., Alberich, S., Rementeria, L., Pérez-Landaluce, I., González-Pinto, A.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564261/ http://dx.doi.org/10.1192/j.eurpsy.2022.1054

Ejemplares similares

Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-Exercise Program (FINEXT-BD Study): Protocol of a Randomized Interventionist Program
por: García, Saínza, et al.
Publicado: (2020)

Cognitive function in bipolar disorder
por: Sparding, T.
Publicado: (2022)

Lithium levels and lifestyle in patients with bipolar disorder: a new tool for self-management
por: Zorrilla, I., et al.
Publicado: (2023)

Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
por: Murueta-Goyena, Ane, et al.
Publicado: (2023)

Identifying a predictive model of cognitive impairment in bipolar disorder patients: a machine learning study
por: Monopoli, C., et al.
Publicado: (2023)

Predictors of functional impairment in patients with bipolar disorder
por: Kartal, C., et al.
Publicado: (2022)

F89. COGNITIVE IMPAIRMENT WORSENING ACROSS AFFECTIVE TO PSYCHOSIS SPECTRUM: A COHORT STUDY OF UNIPOLAR/BIPOLAR DEPRESSION AND BIPOLAR SCHIZOAFFECTIVE DISORDERS
por: Roy, Martin, et al.
Publicado: (2018)

Bipolar disorder and maternity
por: Palomo Monge, M., et al.
Publicado: (2022)

SOD and CAT as potential preliminary biomarkers for the differential diagnosis of schizophrenia and bipolar disorder in the first episode of psychosis
por: Cachán-Vega, C., et al.
Publicado: (2023)

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
por: Tao, Rui, et al.
Publicado: (2019)

Orexins in the clinical course of bipolar disorder
por: Moya-Lacasa, C., et al.
Publicado: (2021)

Impaired cognitive function in healthy offspring of bipolar patients
por: Permoda-Osip, Agnieszka, et al.
Publicado: (2010)

Precision in bipolar disorders
por: Grande, I.
Publicado: (2023)

The role of neuronal network synchronization as a potential biomarker for bipolar disorder
por: Mnif, M., et al.
Publicado: (2023)

Identifying prodromal biomarkers for schizophrenia and bipolar disorder using magnetoencephalography
por: Jefsen, O., et al.
Publicado: (2022)

Orexins and bipolar disorder: A review
por: Moya Lacasa, C., et al.
Publicado: (2022)

The response to unfolded proteins in schizophrenia and bipolar disorder
por: Cachán, C., et al.
Publicado: (2023)

Contextual Social Cognition Impairments in Schizophrenia and Bipolar Disorder
por: Baez, Sandra, et al.
Publicado: (2013)

Cognitive Impairment Mechanism in Patients with Bipolar Disorder
por: Huang, Yanxiong, et al.
Publicado: (2023)

Endocrine biomarkers related to sleep-wake cycle and sleep disturbances in patients with bipolar disorder: A systematic review
por: Gonzalez-Blanco, L., et al.
Publicado: (2022)

C-reactive protein levels and cognitive functions in patients with bipolar disorder
por: Elleuch, O., et al.
Publicado: (2023)

Gut permeability and low-grade inflammation in bipolar disorder
por: Couce, M., et al.
Publicado: (2023)

Prediction of functional outcome in bipolar disorder: Effects of cognitive remediation and cognitive psychoeducational group therapy
por: Sachs, G., et al.
Publicado: (2021)

PS60. Associations between Pro-inflammatory cytokines and grey matter/ cortical thickness in patients with bipolar disorder
por: Bai, Ya-Mei, et al.
Publicado: (2016)

Impulsivity in remitted bipolar disorder
por: Lajmi, I., et al.
Publicado: (2021)

Feasibility of group cognitive behavioural therapy for insomnia (CBT-I) in bipolar disorder
por: Swagemakers, O., et al.
Publicado: (2021)

The Role of The Predominant Polarity on Neurocognitive and Social Cognitive Dysfunctions in Patients with Bipolar Disorder
por: Atay, E., et al.
Publicado: (2023)

Behaviour problems of patients with bipolar disorder
por: Kammoun, I., et al.
Publicado: (2021)

Bipolar affective disorder
por: Young, A.
Publicado: (2021)

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
por: Solé, Brisa, et al.
Publicado: (2017)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

EARLY CHARACTERISTICS AND BIOMARKERS OF COGNITIVE IMPAIRMENT AND DEMENTIA WITH PRIOR MOTOR IMPAIRMENT
por: Tian, Qu, et al.
Publicado: (2022)

Chronotype and biological rhythms in bipolar disorders
por: Ahmed, A. Ben Cheikh, et al.
Publicado: (2021)

PS61. Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder
por: Yoo, Nam Hee, et al.
Publicado: (2016)

Game changer in the diagnosis of bipolar disorder using RNA editing-based blood biomarkers
por: Abraham, J.-D., et al.
Publicado: (2021)

Variation in cognitive insight processes between schizophrenia and bipolar disorder in a Tunisian population
por: Ben Hmida, M.
Publicado: (2022)

Insight and self-esteem in patients with bipolar disorders
por: Hentati, S., et al.
Publicado: (2021)

Subsyndromal symptoms in bipolar disorder
por: Mellouli, A., et al.
Publicado: (2021)

Bipolar disorder’s treatment and impulsivity
por: Ajmi, S., et al.
Publicado: (2021)

Bipolar disorder and multiple sclerosis
por: Maamri, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8j2gaqneg4t0iqla8shjorgd9i